Company Filing History:
Years Active: 2011
Title: Innovations of John McIntyre in Surgical Devices
Introduction
John McIntyre is an accomplished inventor based in Rancho Santa Margarita, California. He has made significant contributions to the field of surgical devices, particularly in the area of revascularization and therapeutic substance delivery.
Latest Patents
McIntyre holds a patent for a surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue. This innovative device is designed to ablate a channel in a patient's tissue while simultaneously delivering a therapeutic agent. The device features an elongated multi-lumen tube, a tissue ablating assembly, and a therapeutic agent delivery assembly. The therapeutic agent can be delivered into the channel or to the surrounding tissue, making it particularly suitable for transmyocardial revascularization operations.
Career Highlights
Throughout his career, McIntyre has been associated with Cardiogenesis Corporation, where he has played a pivotal role in developing advanced surgical technologies. His work has focused on improving patient outcomes through innovative medical devices.
Collaborations
One of McIntyre's notable collaborators is Elbert Tzeng, with whom he has worked on various projects aimed at enhancing surgical procedures and patient care.
Conclusion
John McIntyre's contributions to surgical device innovation demonstrate his commitment to advancing medical technology. His patented device represents a significant step forward in the field of revascularization and therapeutic delivery.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.